By Natalie Grover (Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma…
Moderna generates $18.4 billion in COVID vaccine sales in 2022
(Reuters) – Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022. (Reporting by…
Marketmind: Seeing through another shock
A look at the day ahead in U.S. and global markets from Mike Dolan. Brazil’s weekend political shock reminds world…
Carmaker Stellantis seals batteries material deal with Element 25
MILAN (Reuters) – Carmaker Stellantis has signed a deal with Australian miner Element 25 for the supply of manganese sulphite…
Berkshire Hathaway sells 1.1 million H-shares in China’s BYD
HONG KONG (Reuters) – Berkshire Hathaway, the investment company owned by Warren Buffett, has sold 1.058 million Hong Kong-listed shares…
U.S. Trustee files objection to FTX’s planned asset sales
(Reuters) – A U.S. Trustee filed an objection on Saturday to plans by bankrupt crypto exchange FTX to sell its…
Meta’s Oversight Board tells company to allow ‘death to Khamenei’ posts
By Katie Paul (Reuters) – Meta’s Oversight Board on Monday overturned the company’s decision to remove a Facebook post that…
Tesla offers discount in Singapore on EVs in inventory
SINGAPORE (Reuters) – Tesla has begun offering discounts to electric vehicle buyers in Singapore who agree to purchase existing inventory…
Marketmind: Goodbye to all that
A look at the day ahead in European and global markets from Tom Westbrook: After three years, travellers are streaming…
Column-Funds start 2023 short dollars, eyeing U.S. rate peak: McGeever
By Jamie McGeever ORLANDO, Fla. (Reuters) – Hedge funds have started 2023 betting that U.S. interest rates are close to…